Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of Home Telemonitoring of Infants With Congenital Heart Disease Awaiting Surgery During the First Year of Life
Sponsor: University Hospital, Bordeaux
Summary
Actually, there is no telemonitoring program that includes newborns or infants with congenital heart disease awaiting cardiac intervention. This is a vulnerable period, prone to clinical complications, rehospitalization, parental stress, and requires monitoring with clinical and therapeutic optimization. The aim of the study is to assess the feasibility and acceptability of monitoring newborns and infants with congenital heart disease awaiting cardiac surgery using the Blue-Line home telemonitoring program.
Official title: Feasibility of Home Telemonitoring of Infants With Congenital Heart Disease Awaiting Surgery During the First Year of Life: the Blue-Line Pilot Study
Key Details
Gender
All
Age Range
0 Months - 12 Months
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-06-01
Completion Date
2027-06-01
Last Updated
2025-05-31
Healthy Volunteers
No
Conditions
Interventions
Blue-Line home telemonitoring program
* A dedicated telemonitoring team with nurses and pediatric cardiologist * A dedicated therapeutic patient education programme * A home telemonitoring medical device with a dedicated platform
Locations (2)
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France, France
CHU de Bordeaux - Hôpital Cardiologique Haut Lévêque
Pessac, France, France